Turn Therapeutics Inc.Turn Therapeutics Inc.Turn Therapeutics Inc.

Turn Therapeutics Inc.

No trades
See on Supercharts
Market capitalization
‪142.92 M‬USD
‪−1.77 M‬USD
0.00USD
‪9.12 M‬
Beta (1Y)

About Turn Therapeutics Inc.


CEO
Bradley Burnam
Headquarters
Westlake Village
Founded
2015
ISIN
US90021W1053
FIGI
BBG002QTLH75
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. Its primary development programs focus on dermatological diseases. The company was founded on January 6, 2015 and is headquartered in Westlake Village, CA.

Check out other big names from the same industry as TTRX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Turn Therapeutics Inc. stocks are traded under the ticker TTRX.
TTRX reached its all-time high on Oct 8, 2025 with the price of 13.54 USD, and its all-time low was 8.50 USD and was reached on Oct 10, 2025. View more price dynamics on TTRX chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Turn Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
No, TTRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TTRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Turn Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.